New York hospitals face budget cuts totaling nearly $400 million; Ford Motor and General Electric announce plans to produce 50,000 ventilators in 100 days; federal judges deal setbacks to Republican governors hoping to claim abortion is a nonessential medical procedure amid the coronavirus disease 2019 (COVID-19) crisis.
With many hospitals and medical workers in New York dealing with the intensifying number of patients infected with coronavirus disease 2019 (COVID-19), a funding cut of nearly $400 million is currently being proposed, limiting government funding to hospitals, according to The New York Times. The budget cut was proposed by a panel that New York Governor Andrew Cuomo convened earlier this year before the severity of the virus took hold, with the intention being to control the state’s growing Medicaid program through identifying savings of $2.5 billion.After President Trump announced this past Friday that he will invoke powers under the Defense Production Act to direct manufacturers in producing ventilators, Ford Motor and General Electric (GE) said they plan to produce 50,000 ventilators in 100 days. Reported by Reuters, Ford announced that they will produce the ventilators at a plant in Michigan in cooperation with GE’s healthcare unit, with an additional 30,000 ventilators being planned monthly as needed to treat patients with COVID-19. Additionally, General Motors plans to produce up to 10,000 ventilators a month by this summer.Federal judges blocked Texas, Ohio, and Alabama from including abortion as a nonessential medical procedure, which if upheld, would have forced the delay of the surgeries, according to The Wall Street Journal. The states claimed the need to preserve medical equipment coming from abortion clinics for medical workers in light of the COVID-19 pandemic. The Texas ruling was a temporary restraining order; the judge is expected to consider a longer-term injunction in mid-April.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More